AUSTRALIAN CANCER CARE NETWORK LAUNCHES TO LINK SERVICES TO POPULATION, CLINICIANS & RESEARCHERS
Aims to reduce health system disparities and tackle cancers with low survival rates
The landscape of cancer care in Australia is set to transform with the Australian Government launch in May 2024 of the Australian Comprehensive Cancer Network (ACCN) at the Innovations Showcase event, hosted by Cancer Australia in Sydney, Australia.
The ACCN is a nationally integrated system of cancer care, aimed at enhancing patient experiences and outcomes through coordinated and equitable access, by linking to comprehensive cancer services across Australia. Anchored by Comprehensive Cancer Centres (CCCs), the ACCN strives to deliver evidence-driven prevention, diagnosis, treatment, and support to all Australians affected by cancer.
Comprehensive Cancer Centres (CCCs) will serve as anchors in the ACCN, connecting various cancer control services nationwide. Through building partnerships and harnessing virtual connectivity, CCCs will collaborate with other cancer care centres, academic institutions, Aboriginal Community Controlled Health Services, regional hospitals and allied health services, among others.
While Australia has some of the world’s highest cancer survival rates, not all people experience equal outcomes. There are significant disparities in cancer outcomes for some populations, particularly affecting those in rural and remote regions, as well as Aboriginal and Torres Strait Islander communities.
The ACCN aims to address these disparities, emphasising coordinated and equitable access to comprehensive cancer services irrespective of where a person lives, and marking a significant milestone in the advancement of cancer care in Australia.
Australian Health Journal spoke with Professor Dorothy Keefe CEO, Cancer Australia on the ACCN launch and the network being a major milestone in the Australian Cancer Plan, which was launched at the end of 2023.
Participation in the ACCN is voluntary, with services committing to a set of standards focusing on comprehensive cancer care, equitable access, research excellence, data collection, workforce development, and network connectivity. Importantly, the ACCN will complement existing networks and alliances within the cancer care landscape, fostering collaboration and maximising resources.
All services and professionals involved in cancer care are encouraged to join the ACCN and contribute to this transformative initiative.
“As part of the implementation of the Australian Cancer Plan launched in November, the ACCN represents an essential stage towards achieving our goals of improving cancer outcomes and experiences for all Australians.”, says Professor Keefe.
She points out, “To achieve world class cancer outcomes for all Australians and realise the ambition of the Australian Cancer Plan, we need collective action from all sectors of health care to address issues that contribute to variation in cancer outcomes and experience.”
-
Peak body in child and family services urges prioritising healthcare for kids in care
The Centre for Excellence in Child and Family Welfare (the Centre) is calling on the Australian Government to prioritise healthcare access for children in out-of-home care.
“We have many amazing young people in care with huge potential, but they’re not set up for success,” said Deb Tsorbaris, CEO “Young people and workers tell us that access to health and education assessments is a huge disadvantage.”
-
SAHMRI Celebrates 10 Years of Research
SAHMRI represents an exciting and unique statewide concept, bringing together basic and translational research, South Australia’s three universities and the health system. SAHMRI works in collaboration with its partners to provide a clear focal point for health and medical research, including paving the way for new partnerships, innovative research projects and improved health outcomes.
Executive Director, Professor Maria Makrides spoke to Australian Health Journal about 3 achievements in the past 10 years that have had significant impact
International leadership breakthroughs in leukaemia research
Culturally appropriate Indigenous health research and clinical care
Omega 3 fatty acids as a preterm birth prevention -
Developing the nation’s first Health and Medical Research Strategy
Professor Steve Wesselingh serves as the CEO of NHMRC, having initially trained as an infectious diseases doctor. His career includes prominent roles such as Head of the Infectious Diseases Unit at the Alfred Hospital, Director of the Burnett, Dean of Medicine at Monash University, and the inaugural Director of SAHMRI. Under his leadership, NHMRC plays a critical role in funding health and medical research, allocating approximately a billion dollars annually to investigator-led projects, clinical trials, and various strategic initiatives. NHMRC also collaborates internationally with organisations such as the MRC and the EU, and manages grant allocation for the MRFF, which distributes $650 million each year.
